{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T18:17:51Z","timestamp":1774981071904,"version":"3.50.1"},"reference-count":67,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2021,7,13]],"date-time":"2021-07-13T00:00:00Z","timestamp":1626134400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["BT\/PR31130\/MED\/15\/197\/2019"],"award-info":[{"award-number":["BT\/PR31130\/MED\/15\/197\/2019"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>A fusion chimeric vaccine comprising multiple protective domains of different blood-stage Plasmodium falciparum antigens is perhaps necessary for widening the protective immune responses and reducing the morbidity caused by the disease. Here we continue to build upon the prior work of developing a recombinant fusion chimera protein, His-tagged PfMSP-Fu24, by producing it as a tag-free recombinant protein. In this study, tag-free recombinant PfMSPFu24 (rFu24) was expressed in Escherichia coli, and the soluble protein was purified using a three-step purification involving ammonium sulphate precipitation followed by 2-step ion exchange chromatography procedures and shown that it was highly immunogenic with the human-compatible adjuvant Alhydrogel. We further investigated two dipeptides, phenylalanine-\u03b1, \u03b2-dehydrophenylalanine (F\u0394F) and Leucine-\u03b1, \u03b2-dehydrophenylalanine (L\u0394F) based hydrogels as effective delivery platforms for rFu24. These dipeptides self-assembled spontaneously to form a highly stable hydrogel under physiological conditions. rFu24 was efficiently entrapped in both the F\u2206F and L\u2206F hydrogels, and the three-dimensional (3D) mesh-like structures of the hydrogels remained intact after the entrapment of the antigen. The two hydrogels significantly stimulated rFu24-specific antibody titers, and the sera from the immunized mice showed an invasion inhibitory activity comparable to that of Alhydrogel. Easily synthesized dipeptide hydrogels can be used as an effective antigen delivery platform to induce immune responses.<\/jats:p>","DOI":"10.3390\/vaccines9070782","type":"journal-article","created":{"date-parts":[[2021,7,13]],"date-time":"2021-07-13T22:25:31Z","timestamp":1626215131000},"page":"782","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Production and Immunogenicity of a Tag-Free Recombinant Chimera Based on PfMSP-1 and PfMSP-3 Using Alhydrogel and Dipeptide-Based Hydrogels"],"prefix":"10.3390","volume":"9","author":[{"given":"Gaurav","family":"Anand","sequence":"first","affiliation":[{"name":"Molecular Medicine Group, International Centre for Genetic Engineering and Biotechnology (ICGEB), New Delhi-110067, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9667-678X","authenticated-orcid":false,"given":"Saikat","family":"Biswas","sequence":"additional","affiliation":[{"name":"Molecular Medicine Group, International Centre for Genetic Engineering and Biotechnology (ICGEB), New Delhi-110067, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nitin","family":"Yadav","sequence":"additional","affiliation":[{"name":"Molecular Medicine Group, International Centre for Genetic Engineering and Biotechnology (ICGEB), New Delhi-110067, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paushali","family":"Mukherjee","sequence":"additional","affiliation":[{"name":"Multi Vaccines Development Program, International Centre for Genetic Engineering and Biotechnology (ICGEB Campus), New Delhi-110067, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9875-9549","authenticated-orcid":false,"given":"Virander Singh","family":"Chauhan","sequence":"additional","affiliation":[{"name":"Molecular Medicine Group, International Centre for Genetic Engineering and Biotechnology (ICGEB), New Delhi-110067, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,7,13]]},"reference":[{"key":"ref_1","unstructured":"WHO (2019). World Malaria Report 2019, World Health Organization."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Alonso, P.L., Brown, G., Arevalo-Herrera, M., Binka, F., Chitnis, C., Collins, F., Doumbo, O.K., Greenwood, B., Hall, B.F., and Levine, M.M. (2011). A research agenda to underpin malaria eradication. PLoS Med., 8.","DOI":"10.1371\/journal.pmed.1000406"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"a025627","DOI":"10.1101\/cshperspect.a025627","article-title":"Vaccines to accelerate malaria elimination and eventual eradication","volume":"7","author":"Healer","year":"2017","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1186\/s13063-019-3391-7","article-title":"RTS,S malaria vaccine pilot studies: Addressing the human realities in large-scale clinical trials","volume":"20","author":"Ogutu","year":"2019","journal-title":"Trials"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Tanner, M., Greenwood, B., Whitty, C.J.M., Ansah, E.K., Price, R.N., Dondorp, A.M., Von Seidlein, L., Baird, J.K., Beeson, J.G., and Fowkes, F.J. (2015). Malaria eradication and elimination: Views on how to translate a vision into reality. BMC Med., 13.","DOI":"10.1186\/s12916-015-0384-6"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1179\/136485910X12647085215534","article-title":"Blood-stage malaria vaccines\u2014Recent progress and future challenges","volume":"104","author":"Goodman","year":"2010","journal-title":"Ann. Trop. Med. Parasitol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2ra5","DOI":"10.1126\/scitranslmed.3000257","article-title":"Extreme polymorphism in a vaccine antigen and risk of clinical malaria: Implications for vaccine development","volume":"1","author":"Takala","year":"2009","journal-title":"Sci. Transl. Med."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Wright, G.J., and Rayner, J.C. (2014). Plasmodium falciparum erythrocyte invasion: Combining function with immune evasion. PLoS Pathog., 10.","DOI":"10.1371\/journal.ppat.1003943"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1586\/14760584.2016.1141680","article-title":"Progress and prospects for blood-stage malaria vaccines","volume":"15","author":"Miura","year":"2016","journal-title":"Expert Rev. Vaccines"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1475-2875-11-11","article-title":"A review of malaria vaccine clinical projects based on the WHO rainbow table","volume":"11","author":"Schwartz","year":"2012","journal-title":"Malar. J."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Ogutu, B.R., Apollo, O.J., McKinney, D., Okoth, W., Siangla, J., Dubovsky, F., Tucker, K., Waitumbi, J.N., Diggs, C., and Wittes, J. (2009). Blood stage malaria vaccine eliciting high antigen-specific antibody concentrations confers no protection to young children in Western Kenya. PLoS ONE, 4.","DOI":"10.1371\/journal.pone.0004708"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/1475-2875-8-162","article-title":"Temporal stability of naturally acquired immunity to Merozoite Surface Protein-1 in Kenyan adults","volume":"8","author":"Dent","year":"2009","journal-title":"Malar. J."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"6958","DOI":"10.1073\/pnas.1001323107","article-title":"A prospective analysis of the Ab response to Plasmodium falciparum before and after a malaria season by protein microarray","volume":"107","author":"Crompton","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1056\/NEJMoa1008115","article-title":"A field trial to assess a blood-stage malaria vaccine","volume":"365","author":"Thera","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1007\/s11538-008-9299-0","article-title":"Determining important parameters in the spread of malaria through the sensitivity analysis of a mathematical model","volume":"70","author":"Chitnis","year":"2008","journal-title":"Bull. Math. Biol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/nrmicro2331","article-title":"Artemisinin resistance: Current status and scenarios for containment","volume":"8","author":"Dondorp","year":"2010","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"7433","DOI":"10.1016\/j.vaccine.2015.09.093","article-title":"Recent advances in recombinant protein-based malaria vaccines","volume":"33","author":"Draper","year":"2015","journal-title":"Vaccine"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1083\/jcb.200604136","article-title":"Intramembrane proteolysis mediates shedding of a key adhesin during erythrocyte invasion by the malaria parasite","volume":"174","author":"Hackett","year":"2006","journal-title":"J. Cell Biol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1182\/blood-2014-11-611707","article-title":"Merozoite surface protein 1 recognition of host glycophorin A mediates malaria parasite invasion of red blood cells","volume":"125","author":"Baldwin","year":"2015","journal-title":"Blood"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"14378","DOI":"10.1073\/pnas.1009198107","article-title":"Isolation of viable Plasmodium falciparum merozoites to define erythrocyte invasion events and advance vaccine and drug development","volume":"107","author":"Boyle","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.chom.2015.09.007","article-title":"Processing of Plasmodium falciparum Merozoite Surface Protein MSP1 activates a Spectrin-binding function enabling parasite egress from RBCs","volume":"18","author":"Das","year":"2015","journal-title":"Cell Host Microbe"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1084\/jem.172.1.379","article-title":"A single fragment of a malaria merozoite surface protein remains on the parasite during red cell invasion and is the target of invasion-inhibiting antibodies","volume":"172","author":"Blackman","year":"1990","journal-title":"J. Exp. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1111\/j.1365-2958.2006.05284.x","article-title":"Malaria transmission-blocking antigen, Pfs230, mediates human red blood cell binding to exflagellating male parasites and oocyst production","volume":"61","author":"Eksi","year":"2006","journal-title":"Mol. Microbiol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/infdis\/173.3.765","article-title":"Clinical immunity to Plasmodium falciparum malaria is associated with serum antibodies to the 19-kDa C-terminal fragment of the merozoite surface antigen, PfMSP-1","volume":"173","author":"Egan","year":"1996","journal-title":"J. Infect. Dis."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1017\/S0031182009990515","article-title":"The carboxy-terminus of merozoite surface protein 1: Structure, specific antibodies and immunity to malaria","volume":"136","author":"Holder","year":"2009","journal-title":"Parasitology"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"ofv044","DOI":"10.1093\/ofid\/ofv044","article-title":"Antibody-dependent cellular inhibition is associated with reduced risk against febrile malaria in a longitudinal cohort study involving Ghanaian children","volume":"2","author":"Tiendrebeogo","year":"2015","journal-title":"Open Forum Infect. Dis."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1128\/IAI.68.5.2617-2620.2000","article-title":"Cytophilic immunoglobulin responses to Plasmodium falciparum glutamate-rich protein are correlated with protection against clinical malaria in Dielmo, Senegal","volume":"68","author":"Oeuvray","year":"2000","journal-title":"Infect. Immun."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Courtin, D., Oesterholt, M., Huismans, H., Kusi, K., Milet, J., Badaut, C., Gaye, O., Roeffen, W., Remarque, E.J., and Sauerwein, R. (2009). The quantity and quality of African children\u2019s IgG responses to merozoite surface antigens reflect protection against Plasmodium falciparum malaria. PLoS ONE, 4.","DOI":"10.1371\/journal.pone.0007590"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Sirima, S.B., Tiono, A.B., Ou\u00e9draogo, A., Diarra, A., Lin Ou\u00e9draogo, A., Yaro, J.B., Ou\u00e9draogo, E., Gansan\u00e9, A., Bougouma, E.C., and Konat\u00e9, A.T. (2009). Safety and immunogenicity of the malaria vaccine candidate MSP3 long synthetic peptide in 12\u201324 months-old Burkinabe children. PLoS ONE, 4.","DOI":"10.1371\/annotation\/3221b8d9-038d-4e67-82fa-de6b1233b459"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1128\/IAI.00427-09","article-title":"Plasmodium falciparum merozoite surface protein 1 (MSP-1)-MSP-3 chimeric protein: Immunogenicity determined with human-compatible adjuvants and induction of protective immune response","volume":"78","author":"Mazumdar","year":"2010","journal-title":"Infect. Immun."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1128\/CVI.00179-14","article-title":"Production and preclinical evaluation of Plasmodium falciparum MSP-119 and MSP-311 chimeric protein, PfMSP-Fu24","volume":"21","author":"Gupta","year":"2014","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.immuni.2010.10.002","article-title":"Vaccine adjuvants: Putting innate immunity to work","volume":"33","author":"Coffman","year":"2010","journal-title":"Immunity"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s00441-018-2929-4","article-title":"Recent advances in experimental polyphosphazene adjuvants and their mechanisms of action","volume":"374","author":"Magiri","year":"2018","journal-title":"Cell Tissue Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1038\/nm.3409","article-title":"Key roles of adjuvants in modern vaccines","volume":"19","author":"Reed","year":"2013","journal-title":"Nat. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1590\/S0100-879X2011000600003","article-title":"Trends in adjuvant development for vaccines: DAMPs and PAMPs as potential new adjuvants","volume":"44","author":"Miyaji","year":"2011","journal-title":"Braz. J. Med. Biol. Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.virol.2016.02.024","article-title":"A cationic liposome-DNA complexes adjuvant (JVRS-100) enhances the immunogenicity and cross-protective efficacy of pre-pandemic influenza A (H5N1) vaccine in ferrets","volume":"492","author":"Liu","year":"2016","journal-title":"Virology"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"6283","DOI":"10.1016\/j.vaccine.2011.06.040","article-title":"Enhanced humoral and cell-mediated immune responses after immunization with trivalent influenza vaccine adjuvanted with cationic liposomes","volume":"29","author":"Rosenkrands","year":"2011","journal-title":"Vaccine"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.coi.2009.01.004","article-title":"Mechanism of action of clinically approved adjuvants","volume":"21","author":"Lambrecht","year":"2009","journal-title":"Curr. Opin. Immunol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/nri2510","article-title":"Towards an understanding of the adjuvant action of aluminium","volume":"9","author":"Marrack","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/nature06939","article-title":"Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants","volume":"453","author":"Eisenbarth","year":"2008","journal-title":"Nature"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1089\/ten.tea.2014.0297","article-title":"Biocompatibility and characterization of a peptide amphiphile hydrogel for applications in peripheral nerve regeneration","volume":"21","author":"Black","year":"2015","journal-title":"Tissue Eng. Part A"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"778","DOI":"10.4161\/hv.27332","article-title":"Recent progress in adjuvant discovery for peptide-based subunit vaccines","volume":"10","author":"Azmi","year":"2014","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1039\/C8TB02547A","article-title":"Progress in self-healing hydrogels assembled by host-guest interactions: Preparation and biomedical applications","volume":"7","author":"Jin","year":"2019","journal-title":"J. Mater. Chem. B"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1203\/PDR.0b013e318165f14d","article-title":"Bioengineering approaches to controlled protein delivery","volume":"63","author":"Kobsa","year":"2008","journal-title":"Pediatr. Res."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1021\/bm800404z","article-title":"Stimuli responsive self-assembled hydrogel of a low molecular weight free dipeptide with potential for tunable drug delivery","volume":"9","author":"Panda","year":"2008","journal-title":"Biomacromolecules"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.2217\/nnm.12.201","article-title":"Modified dipeptide-based nanoparticles: Vehicles for targeted tumor drug delivery","volume":"8","author":"Panda","year":"2013","journal-title":"Nanomedicine"},{"key":"ref_47","first-page":"4207","article-title":"Novel dipeptide nanoparticles for effective curcumin delivery","volume":"7","author":"Alam","year":"2012","journal-title":"Int. J. Nanomed."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1166\/jbn.2017.2325","article-title":"Characterization of DNA condensation by conformationally restricted dipeptides and gene delivery","volume":"13","author":"Khatri","year":"2017","journal-title":"J. Biomed. Nanotechnol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1002\/adma.200601774","article-title":"Self-assembly of a dipeptide-containing conformationally restricted dehydrophenylalanine residue to form ordered nanotubes","volume":"19","author":"Gupta","year":"2007","journal-title":"Adv. Mater."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1021\/am1005173","article-title":"3D cell growth and proliferation on a RGD functionalized nanofibrillar hydrogel based on a conformationally restricted residue containing dipeptide","volume":"2","author":"Panda","year":"2010","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"31167","DOI":"10.1038\/srep31167","article-title":"A novel highly stable and injectable hydrogel based on a conformationally restricted ultrashort peptide","volume":"6","author":"Thota","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejps.2011.10.013","article-title":"Controlled release of insulin from self-assembling nanofiber hydrogel, PuraMatrix\u2122: Application for the subcutaneous injection in rats","volume":"45","author":"Nishimura","year":"2012","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/s00449-009-0394-x","article-title":"Identification of cultivation condition to produce correctly folded form of a malaria vaccine based on Plasmodium falciparum merozoite surface protein-1 in Escherichia coli","volume":"33","author":"Mazumdar","year":"2010","journal-title":"Bioprocess Biosyst. Eng."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.vaccine.2006.09.048","article-title":"Immunogenicity of a recombinant malaria vaccine based on receptor binding domain of Plasmodium falciparum EBA-175","volume":"25","author":"Pattnaik","year":"2007","journal-title":"Vaccine"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1126\/science.781840","article-title":"Human malaria parasites in continuous culture","volume":"193","author":"Trager","year":"1976","journal-title":"Science"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S0022-2836(03)00376-0","article-title":"Crystal structure of a Fab complex formed with PfMSP1\u201319, the C-terminal fragment of merozoite surface protein 1 from Plasmodium falciparum: A malaria vaccine candidate","volume":"328","author":"Pizarro","year":"2003","journal-title":"J. Mol. Biol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0166-6851(93)90141-J","article-title":"Monoclonal antibodies that inhibit Plasmodium falciparum invasion in vitro recognise the first growth factor-like domain of merozoite surface protein-1","volume":"60","author":"Chappel","year":"1993","journal-title":"Mol. Biochem. Parasitol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1073\/pnas.0912124107","article-title":"A self-assembling peptide acting as an immune adjuvant","volume":"10","author":"Rudra","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.7150\/thno.30577","article-title":"Injectable polypeptide hydrogel-based co-delivery of vaccine and immune checkpoint inhibitors improves tumor immunotherapy","volume":"9","author":"Song","year":"2019","journal-title":"Theranostics"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"5479","DOI":"10.1016\/j.vaccine.2016.09.044","article-title":"Supramolecular peptide hydrogel adjuvanted subunit vaccine elicits protective antibody responses against West Nile virus","volume":"34","author":"Friedrich","year":"2016","journal-title":"Vaccine"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s11095-018-2442-1","article-title":"Chemotherapeutic delivery from a self-assembling peptide nanofiber hydrogel for the management of Glioblastoma","volume":"35","author":"Karavasili","year":"2018","journal-title":"Pharm. Res."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"102056","DOI":"10.1016\/j.nano.2019.102056","article-title":"Subcutaneous vaccination using injectable biodegradable hydrogels for long-term immune response","volume":"21","author":"Lee","year":"2019","journal-title":"Nanomedicine"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.actbio.2017.03.041","article-title":"Rational design of charged peptides that self-assemble into robust nanofibers as immune-functional scaffolds","volume":"55","author":"Zhang","year":"2017","journal-title":"Acta Biomater."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"3984","DOI":"10.1039\/b821583a","article-title":"Effect of mechanical properties of hydrogel nanoparticles on macrophage cell Uptake","volume":"5","author":"Banquy","year":"2009","journal-title":"Soft Matter"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"3024","DOI":"10.1128\/iai.65.8.3024-3031.1997","article-title":"Characterization of human T- and B-cell epitopes in the C terminus of Plasmodium falciparum merozoite surface protein 1: Evidence for poor T-cell recognition of polypeptides with numerous disulfide bonds","volume":"65","author":"Egan","year":"1997","journal-title":"Infect. Immun."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1021\/acscentsci.0c00732","article-title":"Injectable hydrogels for sustained codelivery of subunit vaccines enhance humoral immunity","volume":"6","author":"Roth","year":"2020","journal-title":"ACS Cent. Sci."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"109232","DOI":"10.1016\/j.matdes.2020.109232","article-title":"A spontaneously formed and self-adjuvanted hydrogel vaccine triggers strong immune responses","volume":"197","author":"He","year":"2021","journal-title":"Mater. Des."}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/9\/7\/782\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:29:52Z","timestamp":1760164192000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/9\/7\/782"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,13]]},"references-count":67,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2021,7]]}},"alternative-id":["vaccines9070782"],"URL":"https:\/\/doi.org\/10.3390\/vaccines9070782","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,13]]}}}